Cargando…

Next‐day residual effects of flibanserin on simulated driving performance in premenopausal women

OBJECTIVE: The objective of this study was to determine the next‐day residual effects of acute and steady‐state nighttime dosing of flibanserin on simulated driving performance and cognitive function in healthy premenopausal women. METHODS: In this randomized, double‐blind, placebo‐controlled, four‐...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kay, Gary G., Hochadel, Thomas, Sicard, Eric, Natarajan, Karthi K., Kim, Noel N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697607/ https://www.ncbi.nlm.nih.gov/pubmed/28568608 http://dx.doi.org/10.1002/hup.2603

Ejemplares similares

Safety and Tolerability of Evening Ethanol Consumption and Bedtime Administration of Flibanserin in Healthy Premenopausal Female Subjects
por: Millheiser, Leah, et al.
Publicado: (2019)

Flibanserin Approval: Facts or Feelings?
por: Simon, James A., et al.
Publicado: (2016)

Effect of Flibanserin Treatment on Body Weight in Premenopausal and Postmenopausal Women with Hypoactive Sexual Desire Disorder: A Post Hoc Analysis
por: Kornstein, Susan G., et al.
Publicado: (2017)

Clinically Meaningful Benefit in Women with Hypoactive Sexual Desire Disorder Treated with Flibanserin
por: Simon, James A., et al.
Publicado: (2022)

Flibanserin for Treating Hypoactive Sexual Desire Disorder
por: Sang, Jae Hong, et al.
Publicado: (2016)

Female sexual dysfunction: a focus on flibanserin
por: Lodise, Nicole M
Publicado: (2017)

Effects of Flibanserin on Subdomain Scores of the Female Sexual Function Index in Women With Hypoactive Sexual Desire Disorder
por: Simon, James A., et al.
Publicado: (2022)

Flibanserin for Low Sexual Desire in Women: A Molecule From Bench to Bed?
por: Basson, Rosemary, et al.
Publicado: (2015)

The Optimization and Evaluation of Flibanserin Fast-Dissolving Oral Films
por: Alghaith, Adel F., et al.
Publicado: (2022)

A randomized, multicenter trial assessing the effects of rapastinel compared to ketamine, alprazolam, and placebo on simulated driving performance
por: Su, Shengfang, et al.
Publicado: (2021)

Flibanserin: Approval of a controversial drug for a controversial disorder
por: Sathyanarayana Rao, T. S., et al.
Publicado: (2015)

Flibanserin: A controversial drug for female hypoactive sexual desire disorder
por: Baid, Rashmi, et al.
Publicado: (2018)

Application of Nanopharmaceutics for Flibanserin Brain Delivery Augmentation Via the Nasal Route
por: Ahmed, Osama A. A., et al.
Publicado: (2020)

New developments in the treatment of hypoactive sexual desire disorder – a focus on Flibanserin
por: Jayne, Christopher J, et al.
Publicado: (2017)

Retinal Neuroprotective Effects of Flibanserin, an FDA-Approved Dual Serotonin Receptor Agonist-Antagonist
por: Coyner, Aaron S., et al.
Publicado: (2016)

Preparation, characterization, dissolution, and permeation of flibanserin − 2-HP-β-cyclodextrin inclusion complexes
por: Alghaith, Adel F., et al.
Publicado: (2021)

Adverse Effects with Finasteride 5 mg/day for Patterned Hair Loss in Premenopausal Women
por: Oliveira-Soares, Rui, et al.
Publicado: (2018)

Optimized Nanostructured Lipid Carriers Integrated into In Situ Nasal Gel for Enhancing Brain Delivery of Flibanserin
por: Fahmy, Usama A, et al.
Publicado: (2020)

Development and Greenness Evaluation of Spectrofluorometric Methods for Flibanserin Determination in Dosage Form and Human Urine Samples
por: Ahmed, Rasha, et al.
Publicado: (2020)

Optimized Nanostructured Lipid Carriers Integrated into in situ Nasal Gel for Enhancing Brain Delivery of Flibanserin [Retraction]
Publicado: (2023)

Biomarkers of mammographic density in premenopausal women
por: His, Mathilde, et al.
Publicado: (2021)

Genomic signature of parity in the breast of premenopausal women
por: Santucci-Pereira, Julia, et al.
Publicado: (2019)

Pooled Analysis Confirms Flibanserin's Unimpressive Efficacy, Raises Measurement Questions: A Commentary on Simon et al
por: Spielmans, Glen I.
Publicado: (2022)

The Effects of Weight Loss on Relative Bone Mineral Density in Premenopausal Women
por: Hamilton, Kara C., et al.
Publicado: (2013)

Birth characteristics of premenopausal women with breast cancer.
por: Le Marchand, L., et al.
Publicado: (1988)

Plasma lipids in premenopausal women with mammographic dysplasia.
por: Boyd, N. F., et al.
Publicado: (1989)

Corneal topographic changes in premenopausal and postmenopausal women
por: Aydin, Erdinc, et al.
Publicado: (2007)

Comparison of the Vaginal Microbiomes of Premenopausal and Postmenopausal Women
por: Gliniewicz, Karol, et al.
Publicado: (2019)

Oncotype DX Recurrence Score in premenopausal women
por: Zhang, Shiliang, et al.
Publicado: (2022)

Ovarian reserve in premenopausal women with breast cancer
por: Zong, Xiangyun, et al.
Publicado: (2022)

Lipidome of mammographic breast density in premenopausal women
por: Getz, Kayla R., et al.
Publicado: (2023)

Metabolic syndrome in premenopausal and postmenopausal women with type 2 diabetes: loss of protective effects of premenopausal status
por: Nakhjavani, Manouchehr, et al.
Publicado: (2014)

Associations of Mitochondrial Fatty Acid Oxidation with Body Fat in Premenopausal Women
por: Warren, Jonathan L., et al.
Publicado: (2017)

A rapid and sensitive UPLC-MS/MS method for the determination of flibanserin in rat plasma: application to a pharmacokinetic study
por: He, Long, et al.
Publicado: (2019)

Spanlastics as a Potential Platform for Enhancing the Brain Delivery of Flibanserin: In Vitro Response-Surface Optimization and In Vivo Pharmacokinetics Assessment
por: Alharbi, Waleed S., et al.
Publicado: (2022)

The effect of time on task, sleep deprivation, and time of day on simulated driving performance
por: Marando, Isabella, et al.
Publicado: (2022)

Multi-Gene Mutation Profiling by Targeted Next-Generation Sequencing in Premenopausal Breast Cancer
por: Zografos, Eleni, et al.
Publicado: (2022)

Effects of soy foods on ovarian function in premenopausal women
por: Wu, A H, et al.
Publicado: (2000)

Oral contraceptive use and risk of melanoma in premenopausal women
por: Feskanich, D, et al.
Publicado: (1999)

Physical activity and risk of breast cancer in premenopausal women
por: Colditz, G A, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_605hsa63aoo039kg4u6r336n6t